Utilization and outcomes of enoxaparin treatment for deep-vein thrombosis in a tertiary-care hospital

American Journal of Hematology

Volumn 65, Issue 4, 2000, Pages 285-288

  Gilbert, Kristine B ^a   Rodgers, George M ^b,c,d  

^a UNIVERSITY OF UTAH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c ARUP LABORATORIES   (United States)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Low molecular weight heparin; Outpatient therapy; Thrombosis

Indexed keywords

ENOXAPARIN; HEPARIN;

ARTICLE; BLEEDING; DEEP VEIN THROMBOSIS; DRUG CONTRAINDICATION; DRUG USE; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; THROMBOEMBOLISM;

ENOXAPARIN; FIBRINOLYTIC AGENTS; HUMANS; OUTPATIENTS; RETROSPECTIVE STUDIES; THROMBOPHLEBITIS; TREATMENT OUTCOME;

EID: 0033739852     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200012)65:4<285::AID-AJH4>3.0.CO;2-5     Document Type: Article

References (15)

1. Antithrombotic therapy for venous thromboembolic disease
2. Low molecular-weight heparin
3. Subcutaneous lowmolecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal vein thrombosis
4. A comparison of low-molecularweight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
5. Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs. intravenous heparin. An economic perspective
6. Inappropriate use of enoxaparin in treatment of deep-vein thrombosis
7. Delayed elimination of enoxaparin in patients with chronic renal insufficiency
8. Enoxaparin: A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders
9. Outpatient treatment of deep vein thrombosis: Translating clinical trials into practice
10. A multicenter clinical trial comparing once and twice daily subcutaneous enoxaparin and intravenous heparin in the treatment of acute deep vein thrombosis
11. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
12. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin
13. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin
14. Criteria for outpatient management of proximal lower extremity deep venous thrombosis
15. Which DVT patients could be considered the best candidates for home therapy?